ArticleObesity (Silver Spring, Md.)2026

Correction to "Setmelanotide in Bardet-Biedl Syndrome: A 52-Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort".

PubMed ↗Publisher ↗

No numbers read from the abstract.